| Stage | NVDA | % of rev | VIAV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $443M | 100.00% | NVDA ×217.15 |
| Gross profit | $72.1B | 74.98% | $262M | 59.06% | NVDA +15.9pp |
| Operating income | $63.7B | 66.24% | $61M | 13.83% | NVDA +52.4pp |
| Pre-tax income | $71.5B | 74.32% | $44M | 9.82% | NVDA +64.5pp |
| Net income | $59.7B | 62.03% | $33M | 7.38% | NVDA +54.7pp |
| Stage | NVDA | VIAV | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $443M100.00% | NVDA ×217.15 |
| Gross profit | 74.98%$72.1B | 59.06%$262M | NVDA +15.9pp |
| Operating income | 66.24%$63.7B | 13.83%$61M | NVDA +52.4pp |
| Pre-tax income | 74.32%$71.5B | 9.82%$44M | NVDA +64.5pp |
| Net income |
| 62.03%$59.7B |
| 7.38%$33M |
| NVDA +54.7pp |
No shared counterparties.